Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Hemodynamic Monitoring Utilizing ClearSight TM System in Suspected Sepsis Patients Presenting to the Emergency Department (CLEAR SEPSIS)

NCT03231956 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03231956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03231956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Hemodynamic Monitoring Utilizing ClearSight TM System in Suspected Sepsis Patients Presenting to the Emergency Department (CLEAR SEPSIS)
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Unknown status
Start date
June 29, 2017
Completion date
June 30, 2022
Enrollment
182 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis